Big Pharma's Secret Weapon: Medicare Starts to Pay Off-Quietly

Pharma companies say Part D is a simple trade: increased volume in exchange for decreased prices. Six months into the program, the deal is working out very well for manufacturers-but don't expect anyone to celebrate just yet.

By Michael McCaughan

When IMS Health released prescription data for January, a lot of people in Big Pharma companies were scratching their heads....

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Market Access

More from Pink Sheet